BMO Capital has increased its price target for Duke Energy (NYSE:DUK) to $143 from $136, maintaining an Outperform rating. The firm anticipates Duke Energy will report first-quarter 2026 earnings on May 5, with investors focusing on regulatory updates and potential growth upside from data center onboarding activity. Despite the stock trading near its 52-week high, InvestingPro data suggests it might be overvalued at its current price of $131.79.

RBC Capital has decreased its price target for Mid-America Apartment Communities (MAA) from $136 to $134, while retaining a Sector Perform rating. This adjustment reflects a recent change in analyst recommendations for the residential REIT. Other firms, including Baird, Evercore ISI, Truist, Morgan Stanley, and Scotiabank, have also recently adjusted their price targets for MAA.

Conagra Brands has appointed John Brase as its new President and Chief Executive Officer, effective June 1, replacing Sean Connolly. Brase previously served as President and COO of The J.M. Smucker Co., bringing a strong track record of leadership in the consumer-packaged goods industry. Connolly, who led Conagra for 11 years, is stepping down from his role and the board of directors.

Haisco Pharmaceutical Group Co. Ltd. has forged an exclusive licensing agreement with AbbVie, granting AbbVie global rights (excluding mainland China, Hong Kong, and Macau) to develop, manufacture, and commercialize novel pain medicines. Haisco will receive an upfront payment of $30 million, with potential for up to $715 million in development, regulatory, and commercial milestone payments, plus tiered royalties on future net sales. This partnership aims to accelerate the global development of innovative pain therapies by leveraging AbbVie's expertise in neuroscience and commercial capabilities.

Oppenheimer has revised its price target for KKR & Co (KKR) to $140, down from the previous $187, while maintaining an "Outperform" rating on the stock. This adjustment comes amidst ongoing market analysis and firm valuations for the investment management and fund operations company. The article also notes other analysts, including BMO Capital and Wolfe Research, have recently adjusted their price targets for KKR.

T. Rowe Price Group (NASDAQ: TROW) reported a decline in assets under management (AUM) to $1.71 trillion at the end of March, down from $1.80 trillion in February, primarily due to market weakness and investor outflows. Despite the overall dip, net outflows improved from $5.3 billion in February to $3.2 billion in March, suggesting a potential stabilization in investor sentiment. The firm's significant equity exposure made it vulnerable to market fluctuations, and future AUM performance will largely depend on market recovery and improved net inflows, especially in its multi-asset and fixed-income offerings.

BMO Capital has increased its price target for CMS Energy (NYSE:CMS) to $86 from $80, maintaining an Outperform rating. The firm anticipates CMS Energy will report positive first-quarter 2026 earnings, driven by rate relief and normalized operations, despite expected increases in operations and maintenance expenses. Investors are also focusing on potential large load contracts and regulatory compacts in Michigan, while InvestingPro analysis suggests the stock might be overvalued despite its consistent dividend increases.

CoStar Group Inc. (US22160N1090) leverages its comprehensive real estate data platforms, like CoStar Suite and LoopNet, to provide crucial insights for commercial real estate decisions in the U.S. and English-speaking markets. The company's subscription-based model and strategic acquisitions, along with its expansion into residential data via Homes.com, position it for sustained growth amid evolving economic conditions and increased demand for data-driven strategies. While analysts generally view CoStar positively for its dominant market position and recurring revenue, they caution on valuation and risks such as prolonged high interest rates and regulatory scrutiny.

The U.S. Securities and Exchange Commission has dismissed its civil enforcement action against FAT Brands, Inc. and several of its executives, including Andrew Wiederhorn, Ron Roe, and Rebecca D. Hershinger. The dismissal, filed on March 27, 2026, was made with prejudice, meaning the claims cannot be refiled, and was based on evidence developed during discovery. This resolution concludes a high-profile securities case without the imposition of monetary penalties or injunctive relief against the defendants.

Day One Biopharmaceuticals (DAWN) stock recently hit a 52-week high of $21.48, showcasing a 201.54% impressive 1-year return and a 130% year-to-date gain, with a market capitalization of $2.22 billion. This surge is likely due to biopharmaceutical advancements and strategic initiatives, despite TradingPro suggesting it's currently overvalued. However, the company is being acquired by Servier for $2.5 billion ($21.50 per share), leading to several analyst downgrades to Neutral or Hold ratings.